Osteoporosis Clinical Trial
Official title:
The Effect of Yoga Asana 'Vrksasana (Tree Pose)' on Balance in the Patients With Osteoporosis
NCT number | NCT03882853 |
Other study ID # | FTR OP |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 30, 2019 |
Est. completion date | December 31, 2019 |
Verified date | September 2020 |
Source | Istanbul Medeniyet University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients with T score of bone mineral densitometry less than or equal to -2.5 will be
included in the study. Initial evaluation consists of obtaining demographic data, performing
international physical activity questionnaire (short form) Additionally; Berg balance test,
timed sit and walk test, single leg stance test, tandem walk test, tandem stance test will be
performed. Baseline static and dynamic balance scores of patients will be determined by the
Corebalance Premiere-19 balance device. After acclimation the device and tests, 3
measurements will be made and the most successful score will be taken. The lowest value will
be showing best performance. After the first evaluation, patients will be randomized using
windows excel randomization option to two groups by another observer. Patients will be
blinded about which exercise group they will be separated to. Both groups will be thought
exercise series which will be based on recommendations which is published on October 2016 by
UK national osteoporosis foundation. Patients would be encouraged to perform the exercises on
recommended basis and handouts will be given to patients in both groups. The yoga group will
also be taught "tree pose".
Patients will be encouraged to note their exercises regularly on daily basis. Patients will
be reevaluated after first and third months and balance tests will be re-performed to
determine the effect of given exercises.
Exclusion criteria
- Neurological or vestibule dysfunctions which may affect balance
- Severe mental disturbances effecting communication
- Locomotor dysfunction which prevents patient to perform balance tests
- Active musculoskeletal pathology which disrupt performing exercises.
Status | Completed |
Enrollment | 32 |
Est. completion date | December 31, 2019 |
Est. primary completion date | June 30, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 35 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Patients with T score of bone mineral densitometry lower than -2.5. Exclusion Criteria: - Neurological or vestibule dysfunctions which may affect balance - Severe mental disturbances effecting communication - Locomotor dysfunction which prevents patient to perform balance tests - Active musculoskeletal pathology which disrupt performing exercises. |
Country | Name | City | State |
---|---|---|---|
Turkey | Istanbul Medeniyet University Faculty of Medicine, Physical Medicine and Rehabilitation Department | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Istanbul Medeniyet University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Static balance score | The Korebalance Premiere-19 device and software will be used to make balance assessment. Static test requires standing steady and balancing on the platform, keeping the cross-hairs of cursor in the center of the test pattern. The score indicates the deviation of user's center of gravity from the center of the pattern. After familirization of the patient to the test, the lowest score of three measurements will be noted. The lowest score gives the most successfull scores of test. | 5 min. | |
Secondary | Dynamic balance score | The Korebalance Premiere-19 device and software will be used to make balance assessment. Dinamic test offers a moving cursor that the user ''follows''. Cursor patterns a clock-wise circle. After familirization of the patient to the test, the lowest score of three measurements will be noted. The lowest score gives the most successfull scores of test. | 5 min. | |
Secondary | Berg balance test score | 14-item scale designed to measure balance of the older adult in a clinical setting. A five-point ordinal scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total Score is 56. Score of 41-56 indicates low fall risk, 21-40 indicates medium fall risk, 0 -20 indicates high fall risk. It is supported a cut off score of 45/56 for independent safe ambulation. | 10 min. | |
Secondary | Timed sit and walk test score | The objective is to determine fall risk and measure the progress of balance, sit to stand and walking. The patient starts in a seated position, the patient stands up upon command, walks 3 meters, turns around, walks back to the chair and sits down. The time stops when the patient is seated. The subject is allowed to use an assistive device. If an assistive device is used, it will be documented. | 1 min. | |
Secondary | Single leg stance test score | It is used to test the static balance and postural control. It is performed eyes open and arms on the hips. The patient must stand unassisted on one leg. The time between one foot is flexed off the floor to the time when it touches the ground. If less then 30 second, it will be noted, patients stands with more than 30 seconds accepted succesfull. | 1 min | |
Secondary | Tandem walk test score | The patient will asked to walk in a straight line with one foot immediately in front of the other (heel to toe) for 10 footstep for each foot. The time will be documented. | 1 min | |
Secondary | Tandem stance test score | The patient will be ask to stand tandem (heel to toe) for 30 seconds. Lower than 30 second will be documented. | 1 min |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A | |
Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A |